Skip to main content
Journal cover image

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

Journal articles
Sarzotti-Kelsoe, M; Cox, J; Cleland, N; Denny, T; Hural, J; Needham, L; Ozaki, D; Rodriguez-Chavez, IR; Stevens, G; Stiles, T; Simkins, A ...
Published in: Retrovirology
January 2009

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Retrovirology

DOI

EISSN

1742-4690

ISSN

1742-4690

Publication Date

January 2009

Volume

6

Issue

Suppl 3

Start / End Page

P206 / P206

Related Subject Headings

  • Virology
  • 3107 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sarzotti-Kelsoe, M., Cox, J., Cleland, N., Denny, T., Hural, J., Needham, L., … Simkins, A. (2009). P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials. Retrovirology, 6(Suppl 3), P206–P206. https://doi.org/10.1186/1742-4690-6-s3-p206
Sarzotti-Kelsoe, M., J. Cox, N. Cleland, T. Denny, J. Hural, L. Needham, D. Ozaki, et al. “P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials.” Retrovirology 6, no. Suppl 3 (January 2009): P206–P206. https://doi.org/10.1186/1742-4690-6-s3-p206.
Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural J, Needham L, et al. P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials. Retrovirology. 2009 Jan;6(Suppl 3):P206–P206.
Sarzotti-Kelsoe, M., et al. “P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials.” Retrovirology, vol. 6, no. Suppl 3, Jan. 2009, pp. P206–P206. Epmc, doi:10.1186/1742-4690-6-s3-p206.
Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural J, Needham L, Ozaki D, Rodriguez-Chavez IR, Stevens G, Stiles T, Tarragona-Fiol T, Simkins A. P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials. Retrovirology. 2009 Jan;6(Suppl 3):P206–P206.
Journal cover image

Published In

Retrovirology

DOI

EISSN

1742-4690

ISSN

1742-4690

Publication Date

January 2009

Volume

6

Issue

Suppl 3

Start / End Page

P206 / P206

Related Subject Headings

  • Virology
  • 3107 Microbiology